Sign In
Get Clay Free →

Suggestions

    Alina Charter

    Global Director, Market Access, Pricing, HEOR and RWE

    Dr. Alina Charter is a pharmaceutical executive with expertise in market access, commercial operations, and rare disease policy.46 She currently serves as the Vice President of Market Access and Policy at Alnylam Pharmaceuticals.2 Dr. Charter has extensive experience in the pharmaceutical industry, with expertise across over 20 therapeutic areas in oncology and pharma.4

    Career Highlights

    • Current Role: Vice President, Market Access and Policy at Alnylam Pharmaceuticals2
    • Previous Experience: Senior Health Economics and Market Access Manager at AstraZeneca Canada1
    • Leadership: Leads teams and drives innovative market access strategies4
    • Recruitment: Involved in recruiting for executive-level positions in the pharmaceutical industry3

    Expertise and Interests

    • Specializes in rare disease policy and advocates for holistic care approaches6
    • Champions patients' access to treatments5
    • Focuses on innovative market access strategies and early access programs3

    Education and Location

    • Holds a DVM (Doctor of Veterinary Medicine) and MSc degree1
    • Education includes studies at SDA Bocconi4
    • Based in Basel, Switzerland4

    Dr. Charter is active on LinkedIn, frequently sharing insights on pharmaceutical industry trends, rare disease policy, and market access strategies.567

    Related Questions

    What are Dr. Alina Charter's main responsibilities at AstraZeneca?
    How has Dr. Alina Charter contributed to rare disease policy?
    What is Dr. Alina Charter's background in oncology and pharma?
    What teams has Dr. Alina Charter led in her career?
    What are Dr. Alina Charter's key achievements at Alnylam Pharmaceuticals?
    Alina Charter
    Alina Charter, photo 1
    Alina Charter, photo 2
    Get intro to Alina
    Add to my network

    Location

    Basel Area, Switzerland